SCHEMBL4846217

SCHEMBL4846217

COc1ccc(C(=O)C=Cc2cc(O)ccc2OCCN(C)C)c(OC)c1OC

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.58
TUBB1 Q9H4B7 3/20 0.53
CAPN1 P07384 2/20 0.51
BACE1 P56817 1/20 0.50
MCL1 Q07820 3/20 0.49
TNFRSF1A P19438 2/20 0.49
NR1H4 Q96RI1 2/20 0.47
ALOX5 P09917 1/20 0.47
PARP1 P09874 1/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
CYP1A1 P04798 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP1B1 Q16678 1/20 0.45
APP P05067 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852831 0.89 TUBB1 (0.50) CHRNA7TUBB1MCL1TNFRSF1AALOX5
SCHEMBL4852346 0.88 CHRNA7 (0.63) CHRNA7TUBB1CAPN1NR1H4ALOX5
SCHEMBL4846198 0.88 CHRNA7 (0.63) CHRNA7TUBB1CAPN1NR1H4ALOX5
SCHEMBL4849390 0.87 ALDH1A1 (0.52) CHRNA7TUBB1TNFRSF1ANR1H4ALOX5
SCHEMBL4855894 0.87 KDM4E (0.48) CHRNA7TUBB1MCL1TNFRSF1AALOX5
SCHEMBL4845551 0.86 MCHR1 (0.49) CHRNA7TUBB1MCL1TNFRSF1AALOX5
SCHEMBL4851981 0.85 CHRNA7 (0.46) CHRNA7TUBB1MCL1TNFRSF1AALOX5
SCHEMBL4845636 0.84 TNFRSF1A (0.49) CHRNA7TUBB1MCL1TNFRSF1AALOX5
SCHEMBL4850165 0.83 TNFRSF1A (0.48) CHRNA7TUBB1MCL1TNFRSF1AALOX5
SCHEMBL4848206 0.83 MCL1 (0.50) CHRNA7TUBB1MCL1TNFRSF1AALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed